Moreover, PD-L-1 expression was upregulated in CD45− tumor cells and in CD45+CD11c+ DCs in MTR-OralGem-treated mice (Figure S3), pointing to effects of oral gemcitabine administration on PD1-PDL1 interactions. This evidence concerns the gene ITGAX and neoplasm.